BB
Benjamin Burnett Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
25
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
76.9%
Neutral
23.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Equal-Weight
Maintained
| $22.50 |
5%
upside
| 2 | – |
–
| 20 Nov ‘25 13 days ago |
|
|
|
Overweight
Maintained
| $35 |
20%
upside
| 2 | +19% |
0
%
| 13 Nov ‘25 20 days ago |
|
|
|
Overweight
Maintained
| $37 |
25%
upside
| 2 | +0.26% |
0
%
| 13 Nov ‘25 20 days ago |
|
|
|
Overweight
Maintained
| $16 |
124%
upside
| 1 | +1.3% |
0
%
| 11 Nov ‘25 22 days ago |
|
|
|
Overweight
Maintained
| $8 |
43%
upside
| 1 | +3.1% |
0
%
| 11 Nov ‘25 22 days ago |
|
|
|
Overweight
Maintained
| $23 |
27%
upside
| 1 | +6.2% |
0
%
| 11 Nov ‘25 22 days ago |
|
|
|
Overweight
Maintained
| $93 |
23%
upside
| 1 | +12% |
0
%
| 5 Nov ‘25 28 days ago |
|
|
|
Overweight
Maintained
| $44 |
1%
downside
| 1 | +6.2% |
0
%
| 4 Nov ‘25 29 days ago |
|
|
|
Overweight
Maintained
| $157 |
6%
upside
| 1 | +9.4% |
0
%
| 4 Nov ‘25 29 days ago |
|
|
|
Equal-Weight
Maintained
| $423 |
12%
downside
| 1 | – |
–
| 30 Oct ‘25 1 month ago |
|